It is not difficult to envision using Riluzole in combination with conventional therapy such as chemotherapy and radiation therapy, which we have already shown to work in synergy with VEGF therapy in various cancers [53] or in a role similar to aromatase inhibitors and Tamoxifen in hormone-responsive breast cancers. The gene discussed is CYP19A1; the disease is cancer.